Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

SET7/9 enzyme affects cell growth and diseases like cancer, diabetes, and obesity.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Two sisters had a rare hair condition without other usual symptoms.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Controlling Tslp can improve health in AEC syndrome patients.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Targeted testing for telogen effluvium patients can save healthcare costs.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

TTD symptoms vary widely, requiring thorough evaluations.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

TSC2 is crucial for proper hair follicle development and patterning.

Trichostasis spinulosa can be diagnosed with a simple skin biopsy and treated with specific gels, but lesions may return after stopping treatment.

Transglutaminase 2 may control sebocyte maturation and lipid metabolism.